|
CCDC115 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.837800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.478180E-01 |
| Normal-vs-Stage2 |
2.890500E-02 |
| Normal-vs-Stage3 |
1.553850E-04 |
| Normal-vs-Stage4 |
3.60799999998829E-06 |
| Stage1-vs-Stage2 |
1.888590E-01 |
| Stage1-vs-Stage3 |
1.124860E-03 |
| Stage1-vs-Stage4 |
4.24960000000585E-05 |
| Stage2-vs-Stage3 |
3.023000E-01 |
| Stage2-vs-Stage4 |
5.481600E-02 |
| Stage3-vs-Stage4 |
2.309000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.336000E-03 |
| Normal-vs-AfricanAmerican |
1.512820E-01 |
| Normal-vs-Asian |
6.660200E-02 |
| Caucasian-vs-AfricanAmerican |
3.909200E-01 |
| Caucasian-vs-Asian |
4.389800E-01 |
| AfricanAmerican-vs-Asian |
3.240600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.237100E-04 |
| Normal-vs-Female |
1.037030E-01 |
| Male-vs-Female |
1.493550E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.491550E-02 |
| Normal-vs-Age(41-60Yrs) |
9.981000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.520500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.016200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.158400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.833000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.239800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.399600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.555600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.522000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.438180E-01 |
| Normal-vs-Grade 2 |
4.695600E-01 |
| Normal-vs-Grade 3 |
1.808169999995E-05 |
| Normal-vs-Grade 4 |
1.42640000033722E-07 |
| Grade 1-vs-Grade 2 |
7.185700E-02 |
| Grade 1-vs-Grade 3 |
8.06960000000467E-05 |
| Grade 1-vs-Grade 4 |
3.75500000004969E-06 |
| Grade 2-vs-Grade 3 |
1.03730000000635E-06 |
| Grade 2-vs-Grade 4 |
2.67680000387571E-08 |
| Grade 3-vs-Grade 4 |
9.257600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.548800E-01 |
| Normal-vs-ccB subtype |
2.8693999953866E-08 |
| ccA subtype-vs-ccB subtype |
8.88178419700125E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.484600E-03 |
| Normal-vs-N1 |
2.584300E-04 |
| N0-vs-N1 |
2.861700E-02 |
|
|
